Ben benieuwd hoe goet Commerzbank vandaag weer zijn best gaat doen om de koers van Galapagos in bedwang te houden. Breakout koers Galapagos is aanstaande.
Watchlist Wednesday: Magic Formula
Mar. 30, 2016 2:49 PM ET| Includes: AAPL, CA, DGX, GILD, VIA, VIAB
Gilead Sciences, Inc. (NASDAQ:GILD) - Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company's products treat conditions such as human immunodeficiency virus (HIV), liver disease, certain blood cancers, hypertension, chronic angina, respiratory systems in cystic fibrosis patients, and influenza A and B. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead has collaboration agreements with Bristol-Myers Squibb Company (NYSE:BMY), Janssen (NYSE:JNJ) R&D Ireland, Japan Tobacco Inc. (OTCPK:JAPAY), and Galapagos NV (OTCPK:GLPYY). The company was founded in 1987 and is headquartered in Foster City, California.
EBIT: $22.2 Billion
Enterprise Value: $148.8 Billion
Net Property, Plant, & Equipment: $2.3 Billion
Net Working Capital: $14.9 Billion
Gilead Sciences staat al aan de voordeur bij Galapagos